clock menu more-arrow no yes

Filed under:

Report: NAC overruled USADA on Frank Mir Adderall exemption for UFC 191

New, comments

Lance Pugmire of The LA Times tweeted that there was a dispute between the Nevada Athletic Commission and the U.S. Anti-Doping Agency regarding UFC heavyweight Frank Mir's use of the forbidden stimulant Adderal prior to his UFC 191 bout with Andrei Arlovski.

Jayne Kamin-Oncea-USA TODAY Sports

The UFC and its drug-testing partner The U.S. Anti-Doping Agency (USADA) has been drawn into the ongoing dispute between the USADA and the Nevada Athletic Commission (NAC). Following yesterday's revelations regarding Floyd Mayweather's use of a saline IV before his May bout with Manny Pacquiao in a blockbuster report by Thomas Hauser on our parent site SBNation.comLA Times reporter Lance Pugmire is tweeting from the NAC and has some revelations regarding UFC heavyweight Frank Mir:

Adderall is a stimulant commonly used for the treatment of attention deficit hyperactivity disorder (ADHD). Mir previously had a therapeutic use exemption (TUE) for testosterone replacement therapy (TRT) before the NAC banned that practice.

Mir lost a decision to Andrei Arlovski at UFC 191.